A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

BACKGROUND: Prostate-specific antigen (PSA) is widely used to detect prostate cancer. The low positive predictive value of elevated PSA results in large numbers of unnecessary prostate biopsies. We set out to determine whether a multivariable model including four kallikrein forms (total, free, and i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Vickers, Andrew J, Cronin, Angel M, Aus, Gunnar, Pihl, Carl-Gustav, Becker, Charlotte, Pettersson, Kim, Scardino, Peter T, Hugosson, Jonas, Lilja, Hans
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2474851/
https://ncbi.nlm.nih.gov/pubmed/18611265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-6-19
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados